Joëlle
Joëlle Amedee, Bordeaux FR
Patent application number | Description | Published |
---|---|---|
20130224277 | POROUS POLYSACCHARIDE SCAFFOLD COMPRISING NANO-HYDROXYAPATITE AND USE FOR BONE FORMATION - The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralisation of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors. | 08-29-2013 |
Joëlle Benessiano, Paris FR
Patent application number | Description | Published |
---|---|---|
20090325194 | USE OF SPLA2 ACTIVITY FOR THE DIAGNOSIS OF A CARDIOVASCULAR EVENT - A method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, includes:—determining the sPLA2 activity of the patient as a first risk marker—determining at least the value of a second risk marker chosen among CRP level, IgM IC of apo B 100 level or IgM MDA-LDL level—determining the ratio (odds ratio) between the value of the sPLA2 activity and the value of the second risk marker and comparing it to a predetermined odds ratio, the odds ratio compared to the predetermined odds ratio being indicative of an increased risk of mortality or of a cardiac and/or vascular event. A new micro method adaptation for automated fluorimetric measurement of serum secretory phospholipase A2 is also disclosed. | 12-31-2009 |
Joëlle Benessiano, Paris FR
Patent application number | Description | Published |
---|---|---|
20090325194 | USE OF SPLA2 ACTIVITY FOR THE DIAGNOSIS OF A CARDIOVASCULAR EVENT - A method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, includes:—determining the sPLA2 activity of the patient as a first risk marker—determining at least the value of a second risk marker chosen among CRP level, IgM IC of apo B 100 level or IgM MDA-LDL level—determining the ratio (odds ratio) between the value of the sPLA2 activity and the value of the second risk marker and comparing it to a predetermined odds ratio, the odds ratio compared to the predetermined odds ratio being indicative of an increased risk of mortality or of a cardiac and/or vascular event. A new micro method adaptation for automated fluorimetric measurement of serum secretory phospholipase A2 is also disclosed. | 12-31-2009 |
Joëlle Corde, Palaiseau FR
Patent application number | Description | Published |
---|---|---|
20130078458 | METHOD FOR THE LOW-TEMPERATURE PREPARATION OF ELECTRICALLY CONDUCTIVE MESOSTRUCTURED COATINGS - The present invention relates to a method for manufacturing mesostructural coatings comprising electrically conductive structures formed of metal nanoparticles. Said method includes the steps that involve: a) depositing on a substrate, a first layer consisting of a silica material, mesostructured by a structuring agent, and a photocatalytic material: b) depositing on the first layer, a second layer of a mesostructural silica material, said second layer being free of photocatalytic material: c) consolidating the first and second layers at at temperature between 50° C. and 250° C.; and d) placing the consolidating coating in contact with a solution that contains and irradiatting coating with a radiation that enables the photocatalytic material to be activated. Said method is characterized in that it includes no heat treatment at a temperature greater than 250° C. | 03-28-2013 |